10x Genomics Inc Ordinary Shares - Class A TXG
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
10x Genomics and Cleveland Clinic Collaborate to Advance Research in Diagnostic Applications of Single Cell and Spatial Technologies in Patients with Bladder Cancer
-
10x Genomics Acquires Proteintech Genomics, a Division Within Proteintech Group
-
10x Genomics Reports First Quarter 2026 Financial Results
-
10x Genomics to Participate in the BofA Securities 2026 Healthcare Conference
-
The Quiet Rule Change Tilting $10B Toward Medtech's Most Validated Platforms
-
10x Genomics Introduces Atera, a New Platform to Redefine How Biology is Measured and Understood
-
10x Genomics to Report First Quarter 2026 Financial Results on May 7, 2026
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Shares Outstanding
- 126.96M
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- 172.03
- Price/Sales
- 7.40
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).
- Sector
- Healthcare
- Industry
- Health Information Services
- Stock Style Box
- Small Core
- Total Number of Employees
- 1,178
- Website
- https://www.10xgenomics.com
Valuation
|
Metric
|
TXG
|
|---|---|
Price/Earnings (Normalized) | 172.03 |
Price/Book Value | 5.94 |
Price/Sales | 7.40 |
Price/Cash Flow | 37.56 |
Price/Earnings
TXG
Financial Strength
|
Metric
|
TXG
|
|---|---|
Quick Ratio | 5.25 |
Current Ratio | 5.90 |
Interest Coverage | — |
Quick Ratio
TXG
Profitability
|
Metric
|
TXG
|
|---|---|
Return on Assets (Normalized) | 2.64% |
Return on Equity (Normalized) | 3.39% |
Return on Invested Capital (Normalized) | 1.09% |
Return on Assets
TXG
Health Information Services Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Veeva Systems Inc Class A
VEEV
| LOCK|thZ!%!j | LOCK|Q>n | $31B | |||
| Pro Medicus Ltd ADR
PMDIY
| — | LOCK|b<c$p | $14B | |||
| Pro Medicus Ltd
PMCUF
| — | LOCK|hF%P | $14B | |||
| BrightSpring Health Services Inc
BTSG
| — | LOCK|>Sw#c | $14B | |||
| Tempus AI Inc Class A common stock
TEM
| — | LOCK|?fC | $10B | |||
| HealthEquity Inc
HQY
| — | LOCK|LNMb% | $8B | |||
| M3 Inc ADR
MTHRY
| — | LOCK|>Z%! | $8B | |||
| Hinge Health Inc Ordinary Shares - Class A
HNGE
| — | LOCK|Jjn | $7B | |||
| Waystar Holding Corp
WAY
| — | LOCK|!T | $4B |
United States